Probiota Americas
2018-10-17 - 2018-10-19 | Singapore, Singapore

Microbiome R&D and Business Collaboration Forum: USA
2018-10-29 - 2018-10-30 | Paradise Point Resort & Spa, 1404 Vacation Rd, San Diego, CA, 92109, United States
As part of its worldwide microbiome series, Global Engage is pleased to announce the 6th Microbiome R&D and Business Collaboration Forum: USA which will be held on 29-30 October, 2018 and will be co-located with the 3rd Probiotics Congress: USA.
Last year’s congress attracted 400 industry, academic and investment leaders to discuss the microbiome in health and disease; challenges and opportunities in moving research towards commercialization; and potential partnerships and collaborations.
Attendees are expected to converge on San Diego this Fall to hear a 70-strong speaker faculty discuss the latest developments; engage in expert-led roundtable discussions and extended panel discussions; analyse the newest biotechs and start-ups worthy of investment; and utilise over seven hours of dedicated networking time to broaden business connections within the field. The Global Engage series is rapidly gaining a fantastic reputation as the number one microbiome networking event. If looking to either learn more from the top scientists in the microbiome and probiotic space; showcase exciting developments in your research; or seek partnerships and funding within the industry; it is a congress not to be missed.

Microbiome Human Nutrition
2018-11-13 - 2018-11-15 | Boston, MA, United States

4th Annual European Microbiome Congress
2018-11-14 - 2018-11-15 | ILEC Conference Centre, 47 Lillie Rd, Fulham, London, SW6 1UD, United Kingdom
The Annual European Microbiome Congress has become a trusted learning and networking platform for leading academics, practicing clinicians, pharmaceutical and nutrition companies, biotech entrepreneurs and investors, government and regulatory bodies and industry leaders who require insight into the latest microbiome research, clinical trials and multi-disciplinary collaborations.

The Microbiome Movement - Drug Development Europe
2019-01-28 - 2019-01-30 | Novotel Paris East, 1 Avenue de la Republique, Paris, 93177, France
Pursuing Disease Causation To Foster The Creation Of Microbiome-Based Therapeutics & Diagnostics
Recent breakthroughs in DNA sequencing, metagenomic analysis and computational techniques have given scientists new insight into the structure and function of the human microbiota, an interconnected community of symbiotic, commensal and pathogenic microorganisms. As valuable clinical data solidifies the importance of the human microbiome on human health and disease, recent efforts have sought to harness this research to create microbiome-based therapeutics.
Situated at the heart of therapeutic R&D, the Microbiome Movement – Drug Development Summit kick starts 2019, once again to help large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.
Set to tackle the greatest scientific, regulatory, clinical, manufacturing and commercialisation challenges across the entire drug development value chain, this meeting will showcase leading industry case studies focused on enhancing the application of novel technologies to standardise results, accelerate target discovery and optimise the translation of microbiome research into safe and effective therapeutic products.
To see the full agenda, speaker list, networking opportunities and more, visit the website.

Phage Futures 2019
2019-01-29 - 2019-01-30 | Washington, Washington, United States
Phage Futures Congress is set to showcase the commercial potential of bacteriophage as biomedical therapy underpinned by successful science, collaboration and clinical data.
Thought leaders from biotechs, academia, big pharma and regulatory authorities will gather to address and resolve clinical and crucial phage application issues in order to progress the field within the Western medical landscape.
Sessions will approach the true potential of phage therapy within microbiome related and infectious disease indications, how to build a regulatory framework for a therapy which doesn’t sit within the traditional structure, and the importance of multidisciplinary phage therapy applications.

North American Microbiome Congress
2019-02-06 - 2019-02-07 | Renaissance Hotel, 999 9TH ST NW, WASHINGTON, WA, 20001, United States
The 4th Annual North America Microbiome Congress in Washington DC, by Kisaco Research, has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require an insight into the latest microbiome research, clinical trials and collaborative partnerships.
With three distinct streams, targeted towards academics, clinicians, and pharma-biotechs, tackling functional understanding, therapeutic development, and preventative approaches respectively, every single moment of your experience at the Congress will be tailored directly to you. We invite you to join us for 2 days of intense learning, mind-sharing and networking opportunities designed to encourage meaningful connections.

Meet and learn from industry leaders
Connect in person with the FDA
Secure funding from the NIH
Network with top academics and clinicians in the field

Probiota 2019
2019-02-13 - 2019-02-15 | Scandic Copenhagen, Vester Søgade 6, Copenhagen, 1601, Denmark
Organised by the publishers of NutraIngredients, Probiota will combine the latest insights from science, regulation and business to provide delegates with the ultimate event to bridge the gap between the worlds of business, regulation, research and product development in the rapidly growing and overlapping fields of probiotics, prebiotics and the microbiome.
On the agenda are engaging sessions on the scientific and commercial potential of the fermented foods trend, dealing with and making sense of big data and bioinformatics, the importance of our microbiome in metabolism. In addition there will be sessions looking at the latest microbiome start-up trailblazers and a deep dive into the growing field of microbiome therapeutics and drug development.
Over the three days there will also be key updates from the IPA, alongside regulatory insights from top experts, and sessions looking at how proposed taxonomic changes will affect your business or research.

Microbiome AgBioTech Summit
2019-02-26 - 2019-02-28 | Hilton Durham, 3800 Hillsborough Rd, Durham, NC, 27705, United States
As microbial-derived products are poised to disrupt the agriculture industry, fundamental challenges remain in understanding the complexity of plant-soil microbial interactions, identifying microbial candidates amenable to fermentation and formulation on a large scale, demonstrating added value of agbiologicals in an agchemical dominated market and delivering agbiological products into the hands of growers.
The 3rd Microbiome Movement – AgBioTech Summit will unite KOLs, agbiotech, agrochemical companies, research institutions and technology experts to harness the plant-soil microbiome and accelerate commercialization of effective next generation agbiologicals.
Join the leaders in agbiological product development as they discuss the latest data-driven case studies and forge collaborations you need to unlock the full potential of the plant-soil microbiome.

Microbiome: Chemical Mechanisms and Biological Consequences
2019-03-10 - 2019-03-14 | Montreal, Canada

Animal Microbiome Congress USA
2019-03-13 - 2019-03-14 | DoubleTree by Hilton Kansas City, Overland Park 10100 College Boulevard, Overland Park, Kansas City, KS, 66210, United States
Following recent bans and restrictions on the use of antibiotic growth promotors in animal feed in both the E.U. and the U.S., a huge movement to find their alternatives has begun. With evidence emerging to support the beneficial effects of microbiome manipulation through prebiotics, probiotics, and other alternative strategies, it is more important than ever to form collaborations to explore how to translate research into commercially viable products, to promote health and improve feed efficiency of livestock animals.
The Animal Microbiome Congress will bring together leading experts including veterinary researchers, animal producers, food retailers, feed and strain manufacturers and animal nutrition and pharmaceutical companies, to showcase unpublished and translatable research, changing consumer priorities, and evidence-based case studies from emerging biotech companies.

Pharmabiotics 2019 Conference & Partnering
2019-03-13 08:00 - 2019-03-14 17:00 (Europe/Athens) | New Cap Event Centre, 3 Quai de Grenelle, Paris, Paris, 75015, France
Pharmabiotics Conference & Partnering is the leading event dedicated to Medicinal Microbiotic Products. Organised by the Pharmabiotic Research Institute, the event consists of an Exhibition, Conference, Startup Pitch Slam and unique One-to-One Partnering Facility, bringing together all actors involved in the international human microbiome community.

Animal Microbiome Congress USA
2019-03-19 - 2019-03-20 | Doubletree by Hilton Kansas City, Overland Park 66212 College Blvd. Overland Park Kansas 66212, Kansas, KS, 10100, United States
The Animal Microbiome Congress USA brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to understand the latest research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering.

Gut Microbiota for Health World Summit 2019
2019-03-23 - 2019-03-24 | InterContinental Miami, 100 Chopin Plaza,, Miami, Florida, FL 33131, United States
Join the American Gastroenterological Association (AGA) and the European Society of Neurogastroenterology and Motility(ESNM) for the 8th annual Gut Microbiota for Health World Summit (GMFH) World Summit. This preeminent meeting on the gut microbiota will take place March 23 & 24, 2019 in Miami, Florida (U.S.).
The 2019 program will present the latest evidence on the interaction between diet, nutrition and the gut microbiome. Learn how diet and nutrition are being used in concert with traditional therapies to manage GI disorders.
The 2019 GMFH World Summit is sponsored by AGA and ESNM, and the scientific committee is co-chaired by Gail Hecht, MD, MS, AGAF, (Loyola University Medical Center, Chicago, Illinois, U.S.) and Francisco Guarner, MD, PhD (Vall d’Hebron University Hospital, Barcelona, Spain). The summit is endorsed by the American Neurogastroenterology and Motility Society (ANMS) and the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), and is made possible through support from Danone (the GMFH Founding Supporter) and Sanofi (Sustaining Supporter).

5th Annual Translational Microbiome Conference
2019-04-16 - 2019-04-18 | Boston, MA, United States
Arrowhead Publishers is pleased to announce the return of its 5th Annual Translational Microbiome Conference to Boston on April 16-18, 2019, taking place at the Westin Copley Place. As the official conference of The Microbiome Coalition (TMBC), the Arrowhead Translational Microbiome Conference was the first microbiome conference in the field to focus exclusively on the hurdles and challenges to commercial success in the space.
Once again, the conference will bring together the leading microbiome companies working to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products across a range of therapeutic areas, from gut to skin and beyond. Expanding on this core focus year on year, we continue to offer informative, hands-on workshops, panels sponsored and directed by industry to focus on your concerns and tightly curated content that goes beyond the usual infomercials to provide tangible and useful insights to how your peers are addressing their commercial approach to the space.
Entering its 5th year in 2019, the meeting will continue to focus and build on the challenges and hurdles that companies working in the microbiome space will have to recognize and navigate in order to successfully commercialize their products. With a broad focus spanning multiple disease states (oncology, dermatology, inflammatory disorders, among others) attendees will have the opportunity to hear the leading companies discuss the work they have underway and how they are meeting these challenges head-on to apply recent discoveries to a variety of disease processes, restoration of health and improved outcomes.

2019 ISAPP Annual Meeting
2019-05-14 08:00 - 2019-05-16 17:00 | Antwerp, Belgium
The 2019 ISAPP Annual Meeting will be held May 14-16th, 2019 at the Radisson Blu Hotel in Antwerp, Belgium.
The 2019 ISAPP meeting is a by-invitation meeting – no open registration is available. The meeting comprises invited experts and representatives from ISAPP’s industry members. ISAPP industry membership includes 2 invitations to the ISAPP annual meeting. See here to learn about ISAPP industry membership.

Microbiome R&D and Business Collaboration Forum: Europe
2019-05-20 - 2019-05-22 | Postilion Convention Centre WTC, Beursplein 37, Rotterdam, 3011 AA, Netherlands
The 6th Microbiome R&D and Business Collaboration Forum is one of the three meetings forming the Microbiome Probiotics Series: Europe.
The 2019 series will bring together more than 400 industry, academic, and investment leaders to discuss the must cutting-edge microbiome research, challenges and opportunities in moving research towards commercialisation, and potential partnerships and collaborations.
For the first time, this event will be three days. As an attendee, you will get more in-depth content on the key challenges and topics facing researchers and product developers, and more time to establish partnerships. Hear from top scientists in the field, meet willing investors and collaborators, and learn about exciting new companies in the microbiome space. With ample networking time and interactive sessions like the roundtable discussions, there will be many opportunities to broaden your connections.

Microbiome Movement – Maternal & Infant Health Summit
2019-05-22 - 2019-05-24 | Boston, MA, United States
The inaugural Microbiome Movement – Maternal & Infant Health Summit has been established to improve your understanding of the fundamental maternal-infant microbiome mechanisms of action and advance translation of this causality into evidence-based and clinically validated therapeutic, nutritional and preventative solutions that will configure healthy foundations of the microbiome within the first 1000 days of life. This first-of-its-kind event is your opportunity to learn from the expertise of key opinion leaders from large pharma, biotech and academic research institutes presenting the latest case studies and in-depth discussion on key topics including:

Discovering the causal relationships between the maternal-infant microbiome and disease onset
Exploring different therapeutic products that restore the infant microbiome, as well as treat and prevent disease
Discussing study design for investigation of the microbiome in maternal and pediatric settings
Understanding the role of the maternal microbiome in preterm birth and infant health outcomes
Optimizing –omics and realizing how to integrate these data with novel pre-clinical modelling to generate clinically meaningful results
Explaining regulatory processes for IND-approved products targeting maternal and infant populations
Addressing public health, economic and educational considerations for commercializing microbiome-based products for mothers and infants

Receive an exclusive 20% discount on your registration when quoting VIP Code 13005MBT.
Visit the website to learn more.

Microbiome Invest
2019-05-23 | London, United Kingdom
The Microbiome Invest Congress 2019 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and health companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
This year we’re hosting our 3rd Annual ‘Pitch Your Microbes’ session – previous winners include Gallinée and TargEDys. This year’s winner will receive a residency with multinational consumer health giant, RB. If you’re a microbiome biotech or an academic with an innovative idea, now’s the time to apply.

IPC 2019
2019-06-17 - 2019-06-20 | Prague, Czech Republic
IPC is the worldwide biggest scientific conference that focuses on probiotics, prebiotics, gut microbiota and health. At IPC leading scientists from industry and academia present current advances in understanding and influencing the interaction between gut microbiota and human health. The goal of conference is to provide a scientific forum for all stakeholders of probiotics, prebiotics and gut health and to enable the interactive exchange of state-of-the-art knowledge. The conference is focused on evidence-based benefits, health claims proven in scientific experiments and clinical trials.
New scientific evidences that support or question the efficiency of already existing or prospective substances and applications will be conferred. In addition novel strains, controversial but scientifically solid ideas, approaches and visions will be presented as well.

Microbiome Movement Drug Development Summit USA
2019-06-26 - 2019-06-28 | Boston, MA, United States
Returning for the fourth year, the Microbiome Movement – Drug Development Summit continues to be the industry-leading forum to help forward thinking researchers from the pharmaceutical, biotech and academic community pursue the causal role of the human microbiome in disease, to create a new generation of targeted treatments that demonstrate consistent clinical outcomes and predictable MoAs.
If you are, or would like to be, a player in the microbiome arena, this is the conference you should attend to not only hear the latest pre-clinical and clinical development from organizations developing microbiome-based therapeutics, biomarkers and diagnostics, but also make long-lasting connections that will accelerate your microbiome developments forward, and help translate this promising science into a reality for patients.
Receive an exclusive 20% discount on your registration when quoting VIP Code 10009MBT.
Visit the website to learn more.

Microbiome Movement – Oncology Response Summit
2019-07-22 - 2019-07-24 | Boston, MA, United States
The inaugural Microbiome Movement – Oncology Response Summit has been established to improve your understanding on how to translate microbiome-oncology research from discovery settings and from retrospective clinical investigations into the routine oncology practice. This first-of-its-kind event is your opportunity to learn from the expertise of key opinion leaders from pre-clinical, translational and clinical scientists from large pharma, biotech and academia presenting the latest case studies and in-depth discussion on key topics including:

Discover the mechanistic pathways underpinning the causality of the microbiome in cancer and consequential effects of cancer therapeutics on microbial dysbiosis
Understand how –omics data are being integrating to inform cancer clinical decision making
Investigate translational applications of the microbiome in cancer 1) to improve clinical safety outcomes, 2) as a validated biomarker to predict patient response and 3) as an LBP monotherapy or adjuvant to enhance therapeutic efficacy (particularly in the context of immunotherapy)
Explore the nutritional interventions for cancer treatment and prevention
Harness clinical experience to establish gold standards for cancer clinical trials incorporating the microbiome as a measurable endpoint
Uncover how to integrate the microbiome into existing oncology medical practice and drug development infrastructures

Receive an exclusive 20% discount on your registration when quoting VIP Code 13017MBT.
Visit the website to learn more.

2nd Microbiome Movement – Animal Health & Nutrition Summit
2019-10-22 - 2019-10-23 | St Louis, MO, United States
As scientific researchers continue to investigate the complexities of the animal microbiome, our mission for the 2nd Microbiome Movement – Animal Health & Nutrition Summit is simple: Unite pioneering industry and academic researchers to lay out the foundational framework around the unique scientific and translational challenges involved in developing and commercializing nutritional and therapeutic solutions that harness the animal microbiome to improve performance and overall health.
Our conversations have highlighted that although a strong commercial opportunity exists, there are critical areas of basic science that need addressing including demonstrating causality of the animal gut microbiome, understanding the impact of antibiotics, integrating –omics approaches with robust study programs that demonstrate product efficacy, as well as navigating regulatory, IP and commercialization pathways to ensure product success.
If you’re keen to make sense of animal microbiome science and its application in both the pet and livestock industries, join your scientifically-driven peers from the nutritional, pharmaceutical and academic community to help you create safe and effective microbiome-targeted products that improve animal health and nutrition.

Exploring Human Host-Microbiome Interactions in Health and Disease
2019-10-23 - 2019-10-25 | Wellcome Genome Campus, United Kingdom
The 8th Exploring Human Host-Microbiome Interactions in Health and Disease meeting will once again bring together leading scientists and clinicians from the fields of microbiology, gastroenterology, neuroscience, cancer and public health to discuss the latest developments in this fast-moving area.
Recent studies have revealed the complexity of the gut microbial ecology and its network connectivity to the metabolic regulation of important pathways in the host. Studies on microbiota from various body sites are helping us to understand how microorganisms affect the host. Alterations in microbiome composition have been associated with many non-infectious diseases including inflammatory bowel conditions, autoimmune diseases, cancers and diabetes, although in many cases causality has yet to be established.
This meeting will update current knowledge of how various microbiomes (skin, oral, gut, lung, non-bacterial etc.) communicate with the host and the factors that influence these interactions. The programme will feature new developments enabled by metagenomics, metabonomics and other technologies. Attendees will have the opportunity to participate in discussions on how to apply recent discoveries to disease processes, health restoration and maintenance.
This year’s meeting will also include sessions on the effects of the microbiome on cancer and how the immune system influences the microbiome and vice versa. As in previous years, the warm welcome given to students and the open friendly atmosphere provide attendees with an enjoyable conference.

Microbiome R&D and Business Collaboration Forum: USA
2019-10-29 - 2019-10-30 | San Diego, CA, United States
Over 100 presentations will be given at the 2019 US series. Over two days discover more about novel research and development trends, explore business and commercialisation strategies, and discover how to translate findings into viable products through collaborative partnerships and funding opportunities. With a focus on metabolic functioning, autoimmune and inflammatory disorders, the gut-brain axis and the relationship between the microbiome and cancer, explore the composition of the gut microbiome, and the tools and technologies used to study microbial communities. This meeting has a reputation for providing an outstanding networking experience in which new collaborations between industry and academia are forged to better translate research into clinical trials. Plus, you will have ample opportunity to review more than 40 poster presentations and meet with 30+ exhibitors showcasing the latest products and services.

First International Conference World of Microbiome: Pregnancy, Birth and Infancy
2019-10-31 - 2019-11-02 | Milan, Italy
The microbiota has profound effects on fetal, neonatal and infant health & development as well as maternal health.
Join the first international platform for all forward-looking professionals, across microbiology, immunology, obstetrics, neonatology, pediatrics and industry.

Discuss the latest findings and their potential impact
Gain knowledge and tools to advance your career in the world of microbiome
Understand how the microbiome affects health and development
Form new collaborations

Be part of the future and mark your calendar for Milan, 31 October – 2 November 2019.

2019 Microbiome Innovation Summit
2019-11-01 | Farmington, CT, United States
The Jackson Laboratory for Genomic Medicine
With support from Connecticut Innovations, The Jackson Laboratory will host the Microbiome Innovation Summit, bringing together experts in all aspects of microbiome research to present the latest research exploring the functions of microbial communities and how knowledge about these systems can be applied in medicine, agriculture, and other fields.
Our goals are to provide an expert overview and stimulating discussion of:

the current landscape in microbiome research and development
approaches for understanding the basis of host/microbe interactions
best practices for experimental design and reproducibility
engineering of microbial systems to meet specific objectives
future directions in microbiome commercialization

The keynote speaker will be Dr. Liping Zhao of Rutgers University, whose lab develops molecular and genomic tools for systems understanding and predictive manipulation of the complex microbial communities in human and animal guts.
Other speakers include Christoph Thaiss, Tami Lieberman, Cara Haney, Alvaro Sanchez, Shipra Vaishnava and more. The full agenda will be available soon.

Pittsburgh Rust Belt Microbiome Conference
2019-11-04 - 2019-11-05 | Pittsburgh, PA, United States
The goal of the Pittsburgh Rust Belt Microbiome (RBM) Conference is to bring together the microbiome, microbial evolution, and pathogenesis research communities from academic institutions and medical centers in the Rust Belt Region.
Our program integrates basic and translational science researchers and physicians in clinical practice at all levels of their careers. Plenary session, keynote talks, poster sessions, lunches, and a banquet dinner will provide multiple opportunities for participants to present and discuss their work.

India|EMBO Symposium – Human microbiome: Resistance and disease
2019-11-09 - 2019-11-12 | Kalyani, India
The importance of Human Microbiome research is rapidly gaining momentum for understanding its role in human health and disease. This requires specialized training in efficient statistical and computational algorithms to analyse the big data generated from high-throughput sequencing platforms and provide valid inferences. The field of microbiome research has witnessed an upsurge of various statistical and bioinformatics methods and softwares without adequate manpower trained in proper usage of such tools. Thus, microbiome studies run the danger of identifying spurious associations in patient cohorts with little biological implications for prediction, prognostication and therapy. The present India|EMBO Symposium, organised by Karen Nelson, Indresh Singh, Harinder Singh from JCVI and Souvik Mukherjee and Partha P Majumder from NIBMG, will cover topics related to recent advancements in human microbiome sequencing, antimicrobial resistance, clinical metagenomics, model based analysis of human microbiome, metatranscriptomics and metaproteomics approaches. This India|EMBO Symposium will also include a satellite workshop on metagenomic data analysis and visualization. The present symposium is a timely step in addressing these relevant topics which will help in the development of a multi-dimensional host-microbiome research environment in India.

3rd Microbiome Movement – Human Nutrition Summit
2019-11-11 - 2019-11-13 | Boston, MA, United States
As researchers continue to uncover the power of the human microbiome to improve health and wellbeing across a diverse list of indications and product applications, the 3rd Microbiome Movement – Human Nutrition Summit proudly returns to Boston as the only meeting that carefully combines cutting-edge basic and clinical science with product developers from the global food, supplement and nutraceutical industry to help develop a new generation of nutritional solutions that target and modulate the human microbiome to promote long-term human health.
Across a comprehensive three day program, this year’s Microbiome Movement – Human Nutrition Summit will continue to address three key topic areas:

Better demonstrate the scientific and clinical efficacy of diet-microbiome interactions across a diverse range of health indications and mechanisms

2. Learn how start-ups, academics and leading nutritional brands are overcoming critical clinical, regulatory and commercialization challenges when utilizing microbiome science to drive the development of personalized nutritional solutions
3. See how microbiome experts are establishing brands that engage their target market, to better communicate the benefits of microbiome research and help differentiate their products from competitors
